Information leaflets for patients with hepatitis C receiving treatment with triple therapy
作者： Inés Yeste-Gómez , Carmen Guadalupe Rodríguez-González , Álvaro Giménez-Manzorro , Arantza Ais-Larisgoitia , María Sanjurjo-Saez
DOI: 10.1136/EJHPHARM-2012-000176
关键词:
摘要: The NS3/4 protease inhibitors boceprevir and telaprevir in conjunction with peginterferon α ribavirin (triple therapy) increase the rate of a sustained virological response patients genotype-1 chronic hepatitis C but, to achieve successful result, good compliance is vital. As part pharmaceutical care programme, Outpatient Pharmacy we developed information leaflets help understand objectives triple therapy, be aware prevent possible side effects teach how take medicines.
sci-hub.se 参考文章(24)
José M. Sánchez Tapias, Tratamiento de la hepatitis crónica C ,(2003)
Nisha Mistry, Jonathan Shapero, Richard I Crawford, A review of adverse cutaneous drug reactions resulting from the use of interferon and ribavirin. Canadian Journal of Gastroenterology & Hepatology. ,vol. 23, pp. 677- 683 ,(2009) , 10.1155/2009/651952
Janet Grime, Alison Blenkinsopp, David K. Raynor, Kristian Pollock, Peter Knapp, The role and value of written information for patients about individual medicines: a systematic review Health Expectations. ,vol. 10, pp. 286- 298 ,(2007) , 10.1111/J.1369-7625.2007.00454.X
Gonzalo Crespo, Sabela Lens, Uso de boceprevir y telaprevir en pacientes con VHC (aspectos prácticos) Gastroenterología y Hepatología. ,vol. 35, pp. 337- 343 ,(2012) , 10.1016/J.GASTROHEP.2011.12.005
Francesco Negro, Adverse effects of drugs in the treatment of viral hepatitis Best Practice & Research Clinical Gastroenterology. ,vol. 24, pp. 183- 192 ,(2010) , 10.1016/J.BPG.2009.10.012
Patrice Cacoub, Marc Bourlière, Jann Lübbe, Nicolas Dupin, Peter Buggisch, Geoffrey Dusheiko, Christophe Hézode, Odile Picard, Ramon Pujol, Siegfried Segaert, Bing Thio, Jean-Claude Roujeau, Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals. Journal of Hepatology. ,vol. 56, pp. 455- 463 ,(2012) , 10.1016/J.JHEP.2011.08.006
Eric Dieperink, Samuel B. Ho, Lori Tetrick, Paul Thuras, Kulwinder Dua, Mark L. Willenbring, Suicidal ideation during interferon-α2b and ribavirin treatment of patients with chronic hepatitis C General Hospital Psychiatry. ,vol. 26, pp. 237- 240 ,(2004) , 10.1016/J.GENHOSPPSYCH.2004.01.003
Morven Cunningham, Graham R. Foster, Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection. Therapeutic Advances in Gastroenterology. ,vol. 5, pp. 139- 151 ,(2012) , 10.1177/1756283X11426895
Armando Sánchez-Quijano, Eduardo Lissen, Tratamiento de las hepatitis víricas (I). Tratamiento de la hepatitis crónica B Enfermedades Infecciosas Y Microbiologia Clinica. ,vol. 24, pp. 453- 462 ,(2006) , 10.1157/13091784
Leonard B. Seeff, Natural history of chronic hepatitis C Hepatology. ,vol. 36, pp. s35- s46 ,(2002) , 10.1053/JHEP.2002.36806